Menu ×


Mucous Membrane Decontamination Market Segmentation by Drug Class (Antibiotics, Corticosteroids, Anti-Inflammatory Drug, and Monoclonal Antibodies); by Product Type (Alcohol and Non-Alcohol Based); by Administration (Injectable, Oral, and Topical); and by Distribution Channel (Drug Store, Online, Retail, and Hospital Pharmacies) – Global Demand Analysis & Opportunity Outlook 2031

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  • Astellas Pharma Inc. announced its global strategic collaboration with Sutro Biopharma, Inc. along with licensing agreement to improvise the development procedure of novel immunostimulatory antibody-drug conjugates shortly known as iADCs.
  • Sun Pharmaceutical Industries Ltd. and it’s entirely owned subsidiaries launch an oral drug, Bempedoic Acid, under the brand name Brillo in India that targets the low-density lipoprotein cholesterol to be decreased. 

Global Mucous Membrane Decontamination Market Size, Forecast, and Trend Highlights Over 2022 - 2031


The global mucous membrane decontamination market is estimated to garner remarkable revenue by the end of 2031 by growing at a CAGR of ~8% over the forecast period, i.e., 2022 – 2031. Further, the market generated noteworthy revenue in the year 2021. The growth of the market can primarily be ascribed to the higher prevalence of healthcare-associated infection. According to the data published by the National Library of Medicine, it was noticed that nearly 1.7 million people patients in hospital facilities acquire healthcare-associated infections (HCAIs) annually while around 98,000 of them die due to these infections, which is 1 in 17 patients across the globe.


Get more information on this report: Request Sample PDF

The mucous membrane is the inner lining of particular organs that is often moist and found in the nose, stomach, mouth, and lungs. Mucous membrane decontamination is the procedure of decrement of the physiological flora along with pathogens. Furthermore, the global mucous membrane decontamination market is estimated to flourish on the back of a higher number of infections associated with wounds. For instance, about 32% of surgical site infections were observed in patients in the year 2019. Additionally, increasing inclination toward infection prevention and control is further projected to enlarge the market size over the forecast period. Hence, all these factors are expected to influence the growth of the market positively during the forecast period. 

Global Mucous Membrane Decontamination Market: Growth Drivers and Challenges

Growth Drivers

  • Spiking Cases of Skin Infection to Boost the Market Growth

For instance, more than 10 million cases of cellulitis are found annually in the United States while on a global basis, approximately 150 per 100,000 patients suffer from cellulitis every year.

Cellulitis is one of the very common bacterial skin infections that can cause swelling, pain, and redness. Cellulitis is the result of bacteria, staphylococcus and streptococcus, entering the skin through a crack. Additionally, cellulitis can trigger serious health problems if it is left untreated.

  • Rising Number of Open Surgery

In the United Kingdom, around 12 thousand coronary artery bypass surgeries were performed from 2019 to 2020.

  • Increasing Inclination of Global Population Toward Personal Hygiene

As of 2020, nearly 65% of people were observed to be utilizing basic hygiene services across the globe.

  • Higher Prevalence of Post-Surgical Wound Infection  

National Library of Medicine published a report showing that 310 million major surgeries are performed worldwide every year.

  • Escalating Prevalence of Autoimmune Diseases 

About 3 million people in the United Kingdom were observed to be suffering from at least one autoimmune disease.


  • Lack of Awareness of the Skin and Autoimmune Diseases
  • Shortage of Required Medication

The global mucous membrane decontamination market is segmented and analyzed for demand and supply by administration into injectable, oral, and topical. Out of these segments, the oral segment is anticipated to hold the notable share in the global mucous membrane decontamination market during the forecast period on account of its convenience availability and consumption, and higher prescription by doctors. Data released by Frontiers in Pharmacology in 2021 demonstrated that nearly 84% of pharmaceutical products are consumed orally.

Major Macro-Economic Indicators Impacting the Market Growth


According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Mucous Membrane Decontamination Market Regional Synopsis

Regionally, the global mucous membrane decontamination market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in the North America region is projected to hold the largest market share by the end of 2031. The market in the region is estimated to witness remarkable growth over the forecast period on the back of the higher prevalence of autoimmune diseases. For instance, in 2017, approximately 22 million Americans were anticipated to have at least one autoimmune disease. The number is further set to rise exponentially over the forecast period. Additionally, the presence of a developed healthcare infrastructure and the growing inclination of people and clinicians toward the utilization of novel drugs are also anticipated to drive the market growth during the forecast period. As of 2020, the national health expenditure of the United States was estimated to be around USD 4 trillion.


The global mucous membrane decontamination market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global mucous membrane decontamination market includes the following segments:



 By Drug Class

  • Antibiotics
  • Corticosteroids
  • Anti-Inflammatory Drug
  • Monoclonal Antibodies


  By Product Type

  • Alcohol
  • Non-Alcohol


  By Administration

  • Injectable
  • Oral
  • Topical



 By Distribution Channel

  • Drug Store
  • Online
  • Retail
  • Hospital Pharmacies

Top Featured Companies Dominating the Global Mucous Membrane Decontamination Market

  • Astellas Pharma Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Bausch Health Companies Inc.
  • Genentech, Inc.
  • Lipidor AB.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Sun Pharmaceutical Industries Ltd.
  • EPI Health, LLC
  • Mölnlycke Health Care AB
  • Reckitt Benckiser Group PLC


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2021 Research Nester. All Rights Reserved